"• Timing uncertain; likely before 5/24/14: FDA action on MNTA’s Copaxone ANDA. The FDA’s new GDUFA guidelines take into account the patent-expiration date of the branded drug (#msg-95940872). "
Is it just as likely that we don't here anything until 5/24?
Market Data 
Markets 
AI
